24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'

R Ferenci; U Bergholz; H Laferl; TM Scherzer; A Maieron; M Gschwantler; H Brunner; RR Hubmann; C Datz; M Bischof; Rudolf Stauber; R Steindl-Munda

24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'

R Ferenci
, U Bergholz
, H Laferl
, TM Scherzer
, A Maieron
, M Gschwantler
, H Brunner
, RR Hubmann
, C Datz
, M Bischof
, Rudolf Stauber
, R Steindl-Munda

Division of Gastroenterology and Hepatology

Research output: Contribution to journal › Conference abstract

14 Citations (Web of Science)

Original language	English
Journal	Journal of Hepatology
Publication status	Published - 2006
Event	41st Annual Meeting of the European Association for the Study of the Liver - Vienna, Austria Duration: 26 Apr 2006 → 30 Apr 2006

Branches of science

302 Clinical Medicine

Links

Web of Science

24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'
Ferenci, R. (Author), Bergholz, U. (Author), Laferl, H. (Author), Scherzer, T. (Author), Maieron, A. (Author), Gschwantler, M. (Author), Brunner, H. (Author), Hubmann, R. (Author), Datz, C. (Author), Bischof, M. (Author), Stauber, R. (Author) & Steindl-Munda, R. (Author)
2006
Activity: Talk, presentation or poster › Scientific talk or presentation › On site

Cite this

@article{effa95ba4f514895bc7620522923c54c,

title = "24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'",

author = "R Ferenci and U Bergholz and H Laferl and TM Scherzer and A Maieron and M Gschwantler and H Brunner and RR Hubmann and C Datz and M Bischof and Rudolf Stauber and R Steindl-Munda",

year = "2006",

language = "English",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

note = "41st Annual Meeting of the European Association for the Study of the Liver, EASL 41 ; Conference date: 26-04-2006 Through 30-04-2006",

}

TY - JOUR

T1 - 24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'

AU - Ferenci, R

AU - Bergholz, U

AU - Laferl, H

AU - Scherzer, TM

AU - Maieron, A

AU - Gschwantler, M

AU - Brunner, H

AU - Hubmann, RR

AU - Datz, C

AU - Bischof, M

AU - Stauber, Rudolf

AU - Steindl-Munda, R

PY - 2006

Y1 - 2006

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000237328100009

M3 - Conference abstract

SN - 0168-8278

JO - Journal of Hepatology

JF - Journal of Hepatology

T2 - 41st Annual Meeting of the European Association for the Study of the Liver

Y2 - 26 April 2006 through 30 April 2006

ER -

24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'

Branches of science

Links

Activities

24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'

Cite this